LOINCActiveBoth

LOINC Code 96757-0: SARS-CoV-2 (COVID-19) S gene codon N501Y Molgen Ql (Specimen)

96757-0 is a LOINC code used to identify SARS-CoV-2 (COVID-19) S gene codon N501Y Molgen Ql (Specimen) in laboratory and clinical observation data. You may see this code in lab systems, lab reports, EHR exports, interoperability feeds, or other structured clinical data exchanges. LOINC codes identify tests, measurements, observations, survey items, and clinical questions in a standardized way. It is associated with the component SARS coronavirus 2 S gene codon N501Y. It is commonly used with the system or sample type XXX.

Reviewed by HealthAssure Clinical TeamUpdated 21 May 2026

What is this code?

LOINC codes identify tests, measurements, observations, survey items, and clinical questions in a standardized way. It is associated with the component SARS coronavirus 2 S gene codon N501Y. It is commonly used with the system or sample type XXX.

When is it used?

  • Used in lab systems, EHRs, and clinical data exchange.
  • May identify a test, observation, survey item, or clinical document request rather than a diagnosis.
  • Status: ACTIVE
  • Order vs observation: Both
  • Method: Molgen

What it does not mean

  • The code identifies the observation or test, not the actual result.

Key facts

SARS-CoV-2 (COVID-19) S gene codon N501Y [Presence] in Specimen by Molecular genetics method
SARS coronavirus 2 S gene codon N501Y
This term is used to report whether the spike protein N501Y codon change (currently a mutation compared to the original strain) was detected in the SARS coronavirus 2 (SARS-CoV-2) strain by molecular methods. To report whether the N501 codon (currently the wild type) was detected, use [LOINC96756-2]. For using a single code to report any mutation found in the S gene, use [LOINC: 96751-3]. To report the SARS-CoV-2 variant strain identified based on the sequencing study, use SARS-CoV-2 (COVID-19) variant [Type] in Specimen [LOINC: 96741-4].
2019 Novel Coronavirus; 2019-nCoV; Corona virus; COVID19; COVID-19; ID; II; Infectious Disease; InfectiousDisease; Microbiology; Misc; Miscellaneous; Molecular genetics; Ordinal; Other; PCR; PH; Point in time; PR; Public Health; PublicHealth; Ql; Qual; Qualitative; Random; S prime; SARS Coronavirus 1; SARS-CoV; SARS-CoV-1; SARS-CoV-2; SARS-CoV-2 S gene; SARS-CoV-2 S gene N501Y; SARS-Related Coronavirus; Screen; Severe Acute Respiratory Syndrome; Spec; To be specified in another part of the message; Unspecified; Viral Pneumonias; Wuhan coronavirus

Where you may see this code

You may see this code in lab systems, lab reports, EHR exports, interoperability feeds, or other structured clinical data exchanges.

Common synonyms

SARS-CoV-2 (COVID-19) S gene codon N501Y Molgen Ql (Specimen)SARS-CoV-2 (COVID-19) S gene codon N501Y [Presence] in Specimen by Molecular genetics methodSARS-CoV-2 S gene N501Y Spec QlSARS coronavirus 2 S gene codon N501YMICROSARS-CoV-2 (COVID-19) S gene codon N501Y, SpecimenPrThr

Frequently asked questions

Code details

Code96757-0
SystemLOINC
Display nameSARS-CoV-2 (COVID-19) S gene codon N501Y Molgen Ql (Specimen)
DescriptionSARS coronavirus 2 S gene codon N501Y
Short nameSARS-CoV-2 S gene N501Y Spec Ql
ComponentSARS coronavirus 2 S gene codon N501Y
PropertyPrThr
TimingPt
System (specimen)XXX
ScaleOrd
MethodMolgen
ClassMICRO
StatusACTIVE
Order/ObservationBoth

Flags

BillableNo
Valid clinical useNo

Source

SourceLOINC
Version2.82
Releasemain
First released2.70
Last changed2.70

Consumer names

SARS-CoV-2 (COVID-19) S gene codon N501Y, Specimen

Part names

SARS coronavirus 2 S gene codon N501YPrThrPtXXXOrdMolgenSARS-CoV-2 (COVID-19) S gene codon N501YPresence or ThresholdPoint in time (spot)Molecular genetics

About this content

This page is prepared by HealthAssure's clinical team using official coding standards from LOINC. AI tools assist with drafting explanations, which are then reviewed and verified by healthcare professionals for accuracy. This content is for informational purposes and does not replace professional medical advice. Meet our team.